FDA Adverse Event Malfunction Summary report: N

FT3 - FREE TRIIODOTHYRONINE

MDR report key: 4892153 · Received July 6, 2015

Report

Report Number
1823260-2015-03756
Event Type
Malfunction
Date Received
July 6, 2015
Date of Event
June 19, 2015
Report Date
July 6, 2015
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CDP
PMA / PMN Number
K963127
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER QUESTIONED RESULTS FROM 1 PATIENT SAMPLE TESTED FOR THYROTROPIN (TSH), FREE THYROXINE (FT4) AND FREE TRIIODOTHYRONINE (FT3). THE CUSTOMER PROVIDED THE SAMPLE FOR INVESTIGATION WHERE ERRONEOUS FT3 RESULTS WERE IDENTIFIED. THE TESTS WERE PERFORMED BETWEEN THE CUSTOMER'S E602 ANALYZER, A CENTAUR ANALYZER, AN E 170 ANALYZER USED AT THE INVESTIGATION SITE AND AN E411 ANALYZER USED AT THE INVESTIGATION SITE. THE DATE OF TESTS PERFORMED AT THE CUSTOMER SITE IS NOT KNOWN. IT IS NOT KNOWN IF ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. REFER TO THE ATTACHMENT TO THE MEDWATCH FOR PATIENT RESULTS. NO ADVERSE EVENT WAS REPORTED. THE E 170 ANALYZER SERIAL NUMBER WAS (B)(4). THE E411 ANALYZER SERIAL NUMBER WAS (B)(4). THE FT3 REAGENT LOT NUMBER USED ON THE E 170 ANALYZER WAS 183221 WITH AN EXPIRATION DATE OF (B)(6) 2016. THE FT3 REAGENT LOT NUMBER USED ON THE E411 ANALYZER WAS 180230 WITH AN EXPIRATION DATE OF 01/31/2015. THE SERIAL NUMBER FOR THE CUSTOMER'S E602 ANALYZER IS NOT KNOWN. A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. BASED ON THE AVAILABLE DATA, A GENERAL REAGENT ISSUE NOT LIKELY. WHEN COMPARING VALUES FROM DIFFERENT TYPES OF ANALYZERS, VARIANCES CAN BE EXPECTED. FOR THYROID PARAMETERS, AGE, GENDER AND OTHER PATIENT CHARACTERISTICS SHOULD BE CONSIDERED WHEN COMPARING VALUES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
436278 FT3 - FREE TRIIODOTHYRONINE RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE CDP ROCHE DIAGNOSTICS NA ASKU

Patients

Seq Age Sex Outcome Treatment
1